Literature DB >> 1929757

Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia.

T L Jernigan1, S Zisook, R K Heaton, J T Moranville, J R Hesselink, D L Braff.   

Abstract

Neuropathologic and brain imaging studies have produced evidence of brain abnormalities in schizophrenic patients, often within the cerebrum's limbic lobe, and, less frequently, within basal ganglia. In the present study we used magnetic resonance imaging morphometric techniques to estimate volumes of specific cerebral structures in schizophrenic patients and age- and sex-matched normal controls. Estimates of the volume of mesial temporal lobe structures were reduced and estimates of the volume of the lenticular nucleus were increased in the schizophrenic patients. There was also evidence of reduced cranial volume in some schizophrenics. The magnitude of the lenticular abnormality, but not the temporal lobe abnormality, was associated with age at first psychiatric contact; earlier onset was associated with larger lenticular nuclei. The possible relevance of these results to neurodevelopmental hypotheses about the pathogenesis of schizophrenia is discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1929757     DOI: 10.1001/archpsyc.1991.01810340013002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  27 in total

Review 1.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.

Authors:  C Konradi; S Heckers
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

Review 2.  MRI anatomy of schizophrenia.

Authors:  R W McCarley; C G Wible; M Frumin; Y Hirayasu; J J Levitt; I A Fischer; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

3.  MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder.

Authors:  James J Levitt; Robert W McCarley; Chandlee C Dickey; Martina M Voglmaier; Margaret A Niznikiewicz; Larry J Seidman; Yoshio Hirayasu; Aleksandra A Ciszewski; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

Review 4.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

5.  The adolescent brain.

Authors:  B J Casey; Sarah Getz; Adriana Galvan
Journal:  Dev Rev       Date:  2008

Review 6.  The adolescent brain.

Authors:  B J Casey; Rebecca M Jones; Todd A Hare
Journal:  Ann N Y Acad Sci       Date:  2008-03       Impact factor: 5.691

7.  Increased head circumference in schizophrenia.

Authors:  A S Bassett; E W Chow; A Bury; F Ali; C A Haylock; G N Smith; J S Lapointe; W G Honer
Journal:  Biol Psychiatry       Date:  1996-12-01       Impact factor: 13.382

8.  Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment.

Authors:  E Zampieri; M Bellani; B Crespo-Facorro; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-22       Impact factor: 6.892

9.  Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.

Authors:  Matthew J Hoptman; Jan Volavka; Elisabeth M Weiss; Pál Czobor; Philip R Szeszko; Guido Gerig; Miranda Chakos; Joseph Blocher; Leslie L Citrome; Jean-Pierre Lindenmayer; Brian Sheitman; Jeffrey A Lieberman; Robert M Bilder
Journal:  Psychiatry Res       Date:  2005-10-25       Impact factor: 3.222

10.  Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.

Authors:  Jianhong Li; Yin Guo; Frederick A Schroeder; Rachael M Youngs; Thomas W Schmidt; Craig Ferris; Christine Konradi; Schahram Akbarian
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.